# EDGAR Filing Document

**Accession Number:** 0001100663
**File Stem:** 0001752724-23-040669
**Filing Date:** 2023-2
**Character Count:** 58062
**Document Hash:** 734dacd00d0868679c6da1f9d2fbe6b8
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001752724-23-040669.hdr.sgml**: 20230224

**ACCESSION NUMBER**: 0001752724-23-040669

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230224

**DATE AS OF CHANGE**: 20230224

**PERIOD START**: 20230331

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** iSHARES TRUST
- **CENTRAL INDEX KEY:** 0001100663
- **IRS NUMBER:** 943351276
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-09729
- **FILM NUMBER:** 23668358

**BUSINESS ADDRESS:**
- **STREET 1:** 400 HOWARD STREET
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94105
- **BUSINESS PHONE:** (415) 670-2000

**MAIL ADDRESS:**
- **STREET 1:** 400 HOWARD STREET
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94105

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ISHARES TRUST
- **DATE OF NAME CHANGE:** 19991213

## Series and Classes Contracts Data

### iShares Global Healthcare ETF (Series ID: S000004372)

| Class ID   | Class Name                    | Ticker Symbol   |
|:---|:---|:---|
| C000012102 | iShares Global Healthcare ETF | IXJ             |

## Nport-Ex

---

| | |
|:---|:---|
| Schedule of Investments (unaudited) | **iShares**<sup>®</sup> **Global Healthcare ETF** |
| December 31, 2022 | **(Percentages shown are based on Net Assets)** |

---

---

| | | |
|:---|:---|:---|
| *Security* | *Shares* | *Value* |
| **Common Stocks**  |  |  |
| **Australia — 1.7%** |  |  |
| Cochlear Ltd. | 41621 | $5748167 |
| CSL Ltd. | 303553 | 59191056 |
| Ramsay Health Care Ltd. | 117381 | 5154328 |
| Sonic Healthcare Ltd. | 300816 | 6121914 |
|  |  | 76215465 |
| **Belgium — 0.4%** |  |  |
| Argenx SE<sup>(a)</sup> | 34644 | 13005554 |
| UCB SA | 79582 | 6270540 |
|  |  | 19276094 |
| **Brazil — 0.1%** |  |  |
| Rede D'Or Sao Luiz SA<sup>(b)</sup> | 470900 | 2630505 |
| **China — 0.4%** |  |  |
| Wuxi Biologics Cayman Inc., New<sup>(a)(b)</sup> | 2238500 | 16954186 |
| **Denmark — 3.8%** |  |  |
| Coloplast A/S, Class B | 74584 | 8737712 |
| Genmab A/S<sup>(a)</sup> | 41223 | 17428870 |
| GN Store Nord A/S | 88938 | 2053282 |
| Novo Nordisk A/S, Class B | 1031122 | 140042414 |
|  |  | 168262278 |
| **France — 2.6%** |  |  |
| EssilorLuxottica SA | 191519 | 34652099 |
| Eurofins Scientific SE<sup>(c)</sup> | 81127 | 5824767 |
| Sanofi | 726064 | 70011832 |
| Sartorius Stedim Biotech | 15062 | 4894667 |
|  |  | 115383365 |
| **Germany — 1.7%** |  |  |
| Bayer AG, Registered | 618432 | 31830725 |
| Fresenius Medical Care AG & Co. KGaA | 126844 | 4143044 |
| Fresenius SE & Co. KGaA | 257691 | 7197795 |
| Merck KGaA | 80967 | 15621791 |
| QIAGEN NV<sup>(a)</sup> | 145767 | 7327780 |
| Siemens Healthineers AG<sup>(b)</sup> | 177253 | 8841662 |
|  |  | 74962797 |
| **Japan — 4.5%** |  |  |
| Astellas Pharma Inc. | 1152375 | 17522586 |
| Chugai Pharmaceutical Co. Ltd. | 397500 | 10138933 |
| Daiichi Sankyo Co.Ltd. | 1225400 | 39441570 |
| Eisai Co. Ltd. | 186500 | 12300054 |
| Hoya Corp. | 224800 | 21531008 |
| M3 Inc. | 269100 | 7309644 |
| Olympus Corp. | 803700 | 14175324 |
| Ono Pharmaceutical Co. Ltd. | 295900 | 6916241 |
| Otsuka Holdings Co. Ltd. | 348600 | 11368800 |
| Shionogi & Co. Ltd. | 178300 | 8895943 |
| Sysmex Corp. | 106000 | 6399281 |
| Takeda Pharmaceutical Co. Ltd. | 995892 | 31118309 |
| Terumo Corp. | 477900 | 13548740 |
|  |  | 200666433 |
| **Netherlands — 0.2%** |  |  |
| Koninklijke Philips NV | 563465 | 8478576 |
| **South Korea — 0.2%** |  |  |
| Celltrion Inc. | 67510 | 8616339 |
| **Spain — 0.0%** |  |  |
| Grifols SA<sup>(a)(c)</sup> | 192675 | 2225090 |

---

---

| | | |
|:---|:---|:---|
| *Security* | *Shares* | *Value* |
| **Sweden — 0.1%** |  |  |
| Getinge AB, Class B | 139192 | $2893884 |
| **Switzerland — 7.7%** |  |  |
| Alcon Inc. | 313425 | 21506895 |
| Lonza Group AG, Registered | 46606 | 22877739 |
| Novartis AG, Registered | 1513135 | 136934811 |
| Roche Holding AG, Bearer | 16764 | 6495984 |
| Roche Holding AG, NVS | 442261 | 138974918 |
| Sonova Holding AG, Registered | 33379 | 7927465 |
| Straumann Holding AG | 73079 | 8380050 |
|  |  | 343097862 |
| **United Kingdom — 4.1%** |  |  |
| AstraZeneca PLC | 975399 | 131990360 |
| GSK PLC | 2522617 | 43598980 |
| Smith & Nephew PLC | 554250 | 7401908 |
|  |  | 182991248 |
| **United States — 72.1%** |  |  |
| Abbott Laboratories | 1096303 | 120363106 |
| AbbVie Inc. | 1113254 | 179912979 |
| Agilent Technologies Inc. | 187384 | 28042016 |
| Align Technology Inc.<sup>(a)</sup> | 45792 | 9657533 |
| AmerisourceBergen Corp. | 101293 | 16785263 |
| Amgen Inc. | 335886 | 88217099 |
| Baxter International Inc. | 314385 | 16024203 |
| Becton Dickinson and Co. | 179527 | 45653716 |
| Biogen Inc.<sup>(a)</sup> | 90979 | 25193905 |
| Bio-Rad Laboratories Inc., Class A<sup>(a)(c)</sup> | 13481 | 5668626 |
| Bio-Techne Corp.<sup>(c)</sup> | 98062 | 8127379 |
| Boston Scientific Corp.<sup>(a)</sup> | 896543 | 41483045 |
| Bristol-Myers Squibb Co. | 1338411 | 96298671 |
| Cardinal Health Inc. | 170013 | 13068899 |
| Catalent Inc.<sup>(a)</sup> | 112744 | 5074607 |
| Centene Corp.<sup>(a)</sup> | 358308 | 29384839 |
| Charles River Laboratories International Inc.<sup>(a)</sup> | 31974 | 6967135 |
| Cigna Corp. | 192461 | 63770028 |
| Cooper Companies Inc. (The)<sup>(c)</sup> | 30967 | 10239858 |
| CVS Health Corp. | 822169 | 76617929 |
| Danaher Corp. | 412424 | 109465578 |
| DaVita Inc.<sup>(a)(c)</sup> | 34712 | 2591945 |
| DENTSPLY SIRONA Inc. | 135638 | 4318714 |
| Dexcom Inc.<sup>(a)</sup> | 246180 | 27877423 |
| Edwards Lifesciences Corp.<sup>(a)</sup> | 388288 | 28970168 |
| Elevance Health Inc. | 150054 | 76973200 |
| Eli Lilly & Co. | 496452 | 181622000 |
| Gilead Sciences Inc. | 789542 | 67782181 |
| HCA Healthcare Inc. | 134891 | 32368444 |
| Henry Schein Inc.<sup>(a)</sup> | 84890 | 6780164 |
| Hologic Inc.<sup>(a)(c)</sup> | 155993 | 11669836 |
| Humana Inc. | 79210 | 40570570 |
| IDEXX Laboratories Inc.<sup>(a)</sup> | 52100 | 21254716 |
| Illumina Inc.<sup>(a)(c)</sup> | 99018 | 20021440 |
| Incyte Corp.<sup>(a)</sup> | 115161 | 9249731 |
| Intuitive Surgical Inc.<sup>(a)</sup> | 223406 | 59280782 |
| IQVIA Holdings Inc.<sup>(a)</sup> | 116938 | 23959427 |
| Johnson & Johnson | 1645810 | 290732336 |
| Laboratory Corp. of America Holdings | 56385 | 13277540 |
| McKesson Corp. | 90001 | 33761175 |
| Medtronic PLC | 836697 | 65028091 |
| Merck & Co. Inc. | 1596026 | 177079085 |
| Mettler-Toledo International Inc.<sup>(a)</sup> | 14066 | 20331700 |

---

---

| | |
|:---|:---|
| Schedule of Investments (unaudited) (continued) | **iShares**<sup>®</sup> **Global Healthcare ETF** |
| December 31, 2022 | **(Percentages shown are based on Net Assets)** |

---

---

| | | |
|:---|:---|:---|
| *Security* | *Shares* | *Value* |
| **United States (continued)** |  |  |
| Moderna Inc.<sup>(a)</sup> | 207370 | $37247799 |
| Molina Healthcare Inc.<sup>(a)</sup> | 36465 | 12041472 |
| Organon & Co. | 160134 | 4472543 |
| PerkinElmer Inc. | 79303 | 11119867 |
| Pfizer Inc. | 3533569 | 181060076 |
| Quest Diagnostics Inc. | 73374 | 11478629 |
| Regeneron Pharmaceuticals Inc.<sup>(a)</sup> | 67408 | 48634198 |
| ResMed Inc. | 91872 | 19121319 |
| STERIS PLC | 62842 | 11606289 |
| Stryker Corp. | 212014 | 51835303 |
| Teleflex Inc. | 29534 | 7372572 |
| Thermo Fisher Scientific Inc. | 246886 | 135957651 |
| UnitedHealth Group Inc. | 588168 | 311834910 |
| Universal Health Services Inc., Class B | 41579 | 5858065 |
| Vertex Pharmaceuticals Inc.<sup>(a)</sup> | 161585 | 46662516 |
| Viatris Inc. | 763674 | 8499692 |
| Waters Corp.<sup>(a)</sup> | 37557 | 12866277 |
| West Pharmaceutical Services Inc. | 46171 | 10866345 |
| Zimmer Biomet Holdings Inc. | 131736 | 16796340 |
| Zoetis Inc. | 293653 | 43034847 |
|  |  | 3199883792 |
| **Total Common Stocks — 99.6%** |  |  |
| &nbsp;&nbsp;&nbsp;**(Cost: $3,679,048,340)** |  | 4422537914 |
| **Preferred Stocks** |  |  |
| **Germany — 0.1%** |  |  |
| Sartorius AG, Preference Shares, NVS | 16806 | 6636279 |
| **Total Preferred Stocks — 0.1%** |  |  |
| &nbsp;&nbsp;&nbsp;**(Cost: $5,913,241)** |  | 6636279 |
| **Total Long-Term Investments — 99.7%** |  |  |
| &nbsp;&nbsp;&nbsp;**(Cost: $3,684,961,581)** |  | 4429174193 |

---

---

| | | |
|:---|:---|:---|
| *Security* | *Shares* | *Value* |
| **Short-Term Securities** |  |  |
| **Money Market Funds — 0.6%** |  |  |
| BlackRock Cash Funds: Institutional, SL Agency Shares, 4.53%<sup>(d)(e)(f)</sup> | 21467097 | $21473537 |
| BlackRock Cash Funds: Treasury, SL Agency Shares, 4.12%<sup>(d)(e)</sup> | 4770000 | 4770000 |
| **Total Short-Term Securities — 0.6%** |  |  |
| &nbsp;&nbsp;&nbsp;**(Cost: $26,236,985)** |  | 26243537 |
| **Total Investments — 100.3%** |  |  |
| &nbsp;&nbsp;&nbsp;**(Cost: $3,711,198,566)** |  | 4455417730 |
| **Liabilities in Excess of Other Assets — (0.3)%** |  | (15296500) |
| **Net Assets — 100.0%** |  | $4440121230 |

---

<sup>(a)</sup> Non-income producing security.

<sup>(b)</sup> Security exempt from registration pursuant to Rule 144A under the Securities Act of 1933, as amended. These securities may be resold in transactions exempt from registration to qualified institutional investors.

<sup>(c)</sup> All or a portion of this security is on loan.

<sup>(d)</sup> Affiliate of the Fund.

<sup>(e)</sup> Annualized 7-day yield as of period end.

<sup>(f)</sup> All or a portion of this security was purchased with the cash collateral from loaned securities.

**Affiliates**

Investments in issuers considered to be affiliate(s) of the Fund during the period ended December 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| *Affiliated Issuer* | *Value at 03/31/22* | *Purchases at Cost* | *Proceeds from Sale* | *Net Realized Gain (Loss)* | *Change in Unrealized Appreciation (Depreciation)* | *Value at 12/31/22* | *Shares <br> Held at <br> 12/31/22* | *Income* | *Capital <br> Gain Distributions from Underlying Funds* |
| BlackRock Cash Funds: Institutional, SL Agency Shares | $6065148 | $15396388 <sup>(a)</sup> | $— | $6660 | $5341 | $21473537 | 21467097 | $23400 <sup>(b)</sup> | $— |
| BlackRock Cash Funds: Treasury, SL Agency Shares | 4860000 |  | (90000)<sup>(a)</sup> |  |  | 4770000 | 4770000 | 87833 | 4 |
|  |  |  |  | $6660 | $5341 | $26243537 |  | $111233 | $4 |

---

<sup>(a)</sup> Represents net amount purchased (sold).

<sup>(b)</sup> All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

---

| | |
|:---|:---|
| Schedule of Investments (unaudited) (continued) | **iShares**<sup>®</sup> **Global Healthcare ETF** |
| December 31, 2022 |  |

---

**Derivative Financial Instruments Outstanding as of Period End**

**Futures Contracts**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  |  |  |  | *Value/* |
|  |  |  | *Notional* | *Unrealized* |
|  | *Number of* | *Expiration* | *Amount* | *Appreciation* |
| *Description* | *Contracts* | *Date* | *(000)* | *(Depreciation)* |
| Long Contracts |  |  |  |  |
| &nbsp;&nbsp;&nbsp;E-Mini Health Care Sector Index | 70 | 03/17/23 | $9676 | $(284626) |

---

**Fair Value Hierarchy as of Period End**

Various inputs are used in determining the fair value of financial instruments. These inputs to valuation techniques are categorized into a fair value hierarchy consisting of three broad levels for financial reporting purposes as follows:

● Level 1 – Unadjusted price quotations in active markets/exchanges for identical assets or liabilities that each Fund has the ability to access;

● Level 2 – Other observable inputs (including, but not limited to, quoted prices for similar assets or liabilities in markets that are active, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the assets or liabilities (such as interest rates, yield curves, volatilities, prepayment speeds, loss severities, credit risks and default rates) or other market-corroborated inputs); and

● Level 3 – Unobservable inputs based on the best information available in the circumstances, to the extent observable inputs are not available (including the Valuation Committee's assumptions used in determining the fair value of financial instruments).

The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Accordingly, the degree of judgment exercised in determining fair value is greatest for instruments categorized in Level 3. The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the fair value hierarchy classification is determined based on the lowest level input that is significant to the fair value measurement in its entirety. Investments classified within Level 3 have significant unobservable inputs used by the Valuation Committee in determining the price for Fair Valued Investments. Level 3 investments include equity or debt issued by privately held companies or funds. There may not be a secondary market, and/or there are a limited number of investors. The categorization of a value determined for financial instruments is based on the pricing transparency of the financial instruments and is not necessarily an indication of the risks associated with investing in those securities. For information about the Fund's policy regarding valuation of financial instruments, refer to its most recent financial statements.

The following table summarizes the Fund's financial instruments categorized in the fair value hierarchy. The breakdown of the Fund's financial instruments into major categories is disclosed in the Schedule of Investments above.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | *Level 1* | *Level 2* | *Level 3* | *Total* |
| Investments |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Assets |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common Stocks | $3199883792 | $1222654122 | $— | $4422537914 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Preferred Stocks |  | 6636279 |  | 6636279 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Money Market Funds | 26243537 |  |  | 26243537 |
|  | $3226127329 | $1229290401 | $— | $4455417730 |
| Derivative financial instruments<sup>(a)</sup> |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Liabilities |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Futures Contracts | $(284626) | $— | $— | $(284626) |

---

<sup>(a)</sup> Derivative financial instruments are futures contracts. Futures contracts are valued at the unrealized appreciation (depreciation) on the instrument.

**Portfolio Abbreviation**

NVS Non-Voting Shares

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** iShares Trust

- **b. Investment Company Act file number:** 811-09729

- **c. CIK number of Registrant:** 0001100663

- **d. LEI of Registrant:** 5493000860OXIC4B5K91

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 400 Howard Street

  - **City:** San Francisco

  - **State:** CA

  - **Foreign country:** US

  - **Zip / Postal Code:** 94105

  - **Telephone number:** 800-474-2737

**Item A.2. Information about the Series.**

- **a. Name of Series:** iShares Global Healthcare ETF

- **b. EDGAR series identifier (if any):** S000004372

- **c. LEI of Series:** 5493008DMA8OZ7F0WV53

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2023-03-31

- **b. Date as of which information is reported:** 2022-12-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $4489544949.50

**Total Liabilities:** $49373682.92

**Net Assets:** $4440171266.58

**Cash Not Reported:** $2730404.32

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000012102 | 8.63%                | 6.03%                | -1.59%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $1811880.26              | $292567814.78                              |
| Month 2  | $15559633.98             | $219121059.57                              |
| Month 3  | $5564433.08              | $-77960995.95                              |

### Schedule of Portfolio Investments

| Name                                           | Title                                                 | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Celltrion Inc                                  | Celltrion Inc                                         | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | KR        |     67510 | NS      | $8616339.42   | 0.19%             |  |  |  | No            |                  2 | On Loan: No      |
| Charles River Laboratories International Inc   | Charles River Laboratories International Inc          | CUSIP: 159864107<br>LEI: 549300BSQ0R4UZ5KX287 | Long             | EC               | CORP              | US        |     31974 | NS      | $6967134.60   | 0.16%             |  |  |  | No            |                  1 | On Loan: No      |
| DENTSPLY SIRONA Inc                            | DENTSPLY SIRONA Inc                                   | CUSIP: 24906P109<br>LEI: 9NHEHR1SOZCYXDO8HO28 | Long             | EC               | CORP              | US        |    135638 | NS      | $4318713.92   | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Chugai Pharmaceutical Co Ltd                   | Chugai Pharmaceutical Co Ltd                          | CUSIP: 000000000<br>LEI: 529900T9LAII161DCN95 | Long             | EC               | CORP              | JP        |    397500 | NS      | $10138932.67  | 0.23%             |  |  |  | No            |                  2 | On Loan: No      |
| Viatris Inc                                    | Viatris Inc                                           | CUSIP: 92556V106<br>LEI: 254900ZZTSW7NL773X71 | Long             | EC               | CORP              | US        |    763674 | NS      | $8499691.62   | 0.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Argenx SE                                      | Argenx SE                                             | CUSIP: 000000000<br>LEI: 7245009C5FZE6G9ODQ71 | Long             | EC               | CORP              | NL        |     34644 | NS      | $13005553.78  | 0.29%             |  |  |  | No            |                  2 | On Loan: No      |
| Vertex Pharmaceuticals Inc                     | Vertex Pharmaceuticals Inc                            | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |    161585 | NS      | $46662516.30  | 1.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson                              | Johnson & Johnson                                     | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |   1645810 | NS      | $290732336.50 | 6.55%             |  |  |  | No            |                  1 | On Loan: No      |
| UnitedHealth Group Inc                         | UnitedHealth Group Inc                                | CUSIP: 91324P102<br>LEI: 549300GHBMY8T5GXDE41 | Long             | EC               | CORP              | US        |    588168 | NS      | $311834910.24 | 7.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Cochlear Ltd                                   | Cochlear Ltd                                          | CUSIP: 000000000<br>LEI: 5493001OLLWY8KV5UC08 | Long             | EC               | CORP              | AU        |     41621 | NS      | $5748166.79   | 0.13%             |  |  |  | No            |                  2 | On Loan: No      |
| PerkinElmer Inc                                | PerkinElmer Inc                                       | CUSIP: 714046109<br>LEI: 549300IKL1SDPFI7N655 | Long             | EC               | CORP              | US        |     79303 | NS      | $11119866.66  | 0.25%             |  |  |  | No            |                  1 | On Loan: No      |
| Straumann Holding AG                           | Straumann Holding AG                                  | CUSIP: 000000000<br>LEI: 50670046ML5FVIM60Z37 | Long             | EC               | CORP              | CH        |     73079 | NS      | $8380049.59   | 0.19%             |  |  |  | No            |                  2 | On Loan: No      |
| AbbVie Inc                                     | AbbVie Inc                                            | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |   1113254 | NS      | $179912978.94 | 4.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Universal Health Services Inc                  | Universal Health Services Inc                         | CUSIP: 913903100<br>LEI: 549300YGMGQDO0NMJD09 | Long             | EC               | CORP              | US        |     41579 | NS      | $5858065.31   | 0.13%             |  |  |  | No            |                  1 | On Loan: —       |
| GN Store Nord AS                               | GN Store Nord AS                                      | CUSIP: 000000000<br>LEI: 5493008U3H3W0NKPFL10 | Long             | EC               | CORP              | DK        |     88938 | NS      | $2053281.96   | 0.05%             |  |  |  | No            |                  2 | On Loan: No      |
| Sonova Holding AG                              | Sonova Holding AG                                     | CUSIP: 000000000<br>LEI: 5299004A0QNX7FBNHS61 | Long             | EC               | CORP              | CH        |     33379 | NS      | $7927465.46   | 0.18%             |  |  |  | No            |                  2 | On Loan: No      |
| Olympus Corp                                   | Olympus Corp                                          | CUSIP: 000000000<br>LEI: 5299000Y52IFDI1I2A21 | Long             | EC               | CORP              | JP        |    803700 | NS      | $14175323.54  | 0.32%             |  |  |  | No            |                  2 | On Loan: No      |
| Thermo Fisher Scientific Inc                   | Thermo Fisher Scientific Inc                          | CUSIP: 883556102<br>LEI: HCHV7422L5HDJZCRFL38 | Long             | EC               | CORP              | US        |    246886 | NS      | $135957651.34 | 3.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Agilent Technologies Inc                       | Agilent Technologies Inc                              | CUSIP: 00846U101<br>LEI: QUIX8Y7A2WP0XRMW7G29 | Long             | EC               | CORP              | US        |    187384 | NS      | $28042015.60  | 0.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Ramsay Health Care Ltd                         | Ramsay Health Care Ltd                                | CUSIP: 000000000<br>LEI: 549300QBX122KF2JPI10 | Long             | EC               | CORP              | AU        |    117381 | NS      | $5154328.51   | 0.12%             |  |  |  | No            |                  2 | On Loan: No      |
| Novo Nordisk A/S                               | Novo Nordisk A/S                                      | CUSIP: 000000000<br>LEI: 549300DAQ1CVT6CXN342 | Long             | EC               | CORP              | DK        |   1031122 | NS      | $140042414.20 | 3.15%             |  |  |  | No            |                  2 | On Loan: No      |
| Getinge AB                                     | Getinge AB                                            | CUSIP: 000000000<br>LEI: 5493003PZ4F570G3W735 | Long             | EC               | CORP              | SE        |    139192 | NS      | $2893884.46   | 0.07%             |  |  |  | No            |                  2 | On Loan: No      |
| DaVita Inc                                     | DaVita Inc                                            | CUSIP: 23918K108<br>LEI: M2XHYMU3TZNEZURC6H66 | Long             | EC               | CORP              | US        |     34712 | NS      | $2591945.04   | 0.06%             |  |  |  | No            |                  1 | On Loan: —       |
| Medtronic PLC                                  | Medtronic PLC                                         | CUSIP: 000000000<br>LEI: 549300GX3ZBSQWUXY261 | Long             | EC               | CORP              | IE        |    836697 | NS      | $65028090.84  | 1.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Centene Corp                                   | Centene Corp                                          | CUSIP: 15135B101<br>LEI: 549300Z7JJ4TQSQGT333 | Long             | EC               | CORP              | US        |    358308 | NS      | $29384839.08  | 0.66%             |  |  |  | No            |                  1 | On Loan: No      |
| Genmab A/S                                     | Genmab A/S                                            | CUSIP: 000000000<br>LEI: 529900MTJPDPE4MHJ122 | Long             | EC               | CORP              | DK        |     41223 | NS      | $17428869.49  | 0.39%             |  |  |  | No            |                  2 | On Loan: No      |
| Roche Holding AG                               | Roche Holding AG                                      | CUSIP: 000000000<br>LEI: 549300U41AUUVOAAOB37 | Long             | EC               | CORP              | CH        |    442261 | NS      | $138974918.11 | 3.13%             |  |  |  | No            |                  2 | On Loan: No      |
| Zoetis Inc                                     | Zoetis Inc                                            | CUSIP: 98978V103<br>LEI: 549300HD9Q1LOC9KLJ48 | Long             | EC               | CORP              | US        |    293653 | NS      | $43034847.15  | 0.97%             |  |  |  | No            |                  1 | On Loan: No      |
| Siemens Healthineers AG                        | Siemens Healthineers AG                               | CUSIP: 000000000<br>LEI: 529900QBVWXMWANH7H45 | Long             | EC               | CORP              | DE        |    177253 | NS      | $8841661.86   | 0.20%             |  |  |  | No            |                  2 | On Loan: No      |
| Boston Scientific Corp                         | Boston Scientific Corp                                | CUSIP: 101137107<br>LEI: Y6ZDD9FP4P8JSSJMW954 | Long             | EC               | CORP              | US        |    896543 | NS      | $41483044.61  | 0.93%             |  |  |  | No            |                  1 | On Loan: No      |
| Zimmer Biomet Holdings Inc                     | Zimmer Biomet Holdings Inc                            | CUSIP: 98956P102<br>LEI: 2P2YLDVPES3BXQ1FRB91 | Long             | EC               | CORP              | US        |    131736 | NS      | $16796340.00  | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Otsuka Holdings Co Ltd                         | Otsuka Holdings Co Ltd                                | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | JP        |    348600 | NS      | $11368800.04  | 0.26%             |  |  |  | No            |                  2 | On Loan: No      |
| ResMed Inc                                     | ResMed Inc                                            | CUSIP: 761152107<br>LEI: 529900T3QE5253CCXF22 | Long             | EC               | CORP              | US        |     91872 | NS      | $19121319.36  | 0.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Elevance Health Inc                            | Elevance Health Inc                                   | CUSIP: 036752103<br>LEI: 8MYN82XMYQH89CTMTH67 | Long             | EC               | CORP              | US        |    150054 | NS      | $76973200.38  | 1.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Biogen Inc                                     | Biogen Inc                                            | CUSIP: 09062X103<br>LEI: W8J5WZB5IY3K0NDQT671 | Long             | EC               | CORP              | US        |     90979 | NS      | $25193904.68  | 0.57%             |  |  |  | No            |                  1 | On Loan: No      |
| Daiichi Sankyo Co Ltd                          | Daiichi Sankyo Co Ltd                                 | CUSIP: 000000000<br>LEI: 353800XGIU2IHQGC9504 | Long             | EC               | CORP              | JP        |   1225400 | NS      | $39441570.43  | 0.89%             |  |  |  | No            |                  2 | On Loan: No      |
| BlackRock Funds III                            | BlackRock Cash Funds: Institutional, SL Agency Shares | CUSIP: 066922519<br>LEI: 5493008LW2651I1QB503 | Long             | STIV             | RF                | US        |  23847400 | NS      | $23854553.90  | 0.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Koninklijke Philips NV                         | Koninklijke Philips NV                                | CUSIP: 000000000<br>LEI: H1FJE8H61JGM1JSGM897 | Long             | EC               | CORP              | NL        |    563465 | NS      | $8478575.60   | 0.19%             |  |  |  | No            |                  2 | On Loan: No      |
| Sartorius AG                                   | Sartorius AG                                          | CUSIP: 000000000<br>LEI: 529900EQV2DY4FOAMU38 | Long             | EP               | CORP              | DE        |     16806 | NS      | $6636279.15   | 0.15%             |  |  |  | No            |                  2 | On Loan: No      |
| Align Technology Inc                           | Align Technology Inc                                  | CUSIP: 016255101<br>LEI: 549300N5YSE0U3LCP840 | Long             | EC               | CORP              | US        |     45792 | NS      | $9657532.80   | 0.22%             |  |  |  | No            |                  1 | On Loan: No      |
| Becton Dickinson and Co                        | Becton Dickinson and Co                               | CUSIP: 075887109<br>LEI: ICE2EP6D98PQUILVRZ91 | Long             | EC               | CORP              | US        |    179527 | NS      | $45653716.10  | 1.03%             |  |  |  | No            |                  1 | On Loan: No      |
| IQVIA Holdings Inc                             | IQVIA Holdings Inc                                    | CUSIP: 46266C105<br>LEI: 549300W3R20NM4KQPH86 | Long             | EC               | CORP              | US        |    116938 | NS      | $23959426.82  | 0.54%             |  |  |  | No            |                  1 | On Loan: —       |
| Moderna Inc                                    | Moderna Inc                                           | CUSIP: 60770K107<br>LEI: 549300EI6OKH5K5Q2G38 | Long             | EC               | CORP              | US        |    207370 | NS      | $37247799.40  | 0.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Stryker Corp                                   | Stryker Corp                                          | CUSIP: 863667101<br>LEI: 5493002F0SC4JTBU5137 | Long             | EC               | CORP              | US        |    212014 | NS      | $51835302.86  | 1.17%             |  |  |  | No            |                  1 | On Loan: No      |
| M3 Inc                                         | M3 Inc                                                | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | JP        |    269100 | NS      | $7309644.41   | 0.16%             |  |  |  | No            |                  2 | On Loan: No      |
| GSK PLC                                        | GSK PLC                                               | CUSIP: 000000000<br>LEI: 5493000HZTVUYLO1D793 | Long             | EC               | CORP              | GB        |   2522617 | NS      | $43598980.00  | 0.98%             |  |  |  | No            |                  2 | On Loan: No      |
| BLACKROCK CASH FUNDS TREASURY SL AGENCY SHARES | BlackRock Cash Funds: Treasury, SL Agency Shares      | CUSIP: 066922477<br>LEI: 5493008LW2651I1QB503 | Long             | STIV             | RF                | US        |   4770000 | NS      | $4770000.00   | 0.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Cigna Corp                                     | Cigna Corp                                            | CUSIP: 125523100<br>LEI: 549300VIWYMSIGT1U456 | Long             | EC               | CORP              | US        |    192461 | NS      | $63770027.74  | 1.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Wuxi Biologics Cayman Inc                      | Wuxi Biologics Cayman Inc                             | CUSIP: 000000000<br>LEI: 5493001TD2TH6VDTJU11 | Long             | EC               | CORP              | KY        |   2238500 | NS      | $16954185.83  | 0.38%             |  |  |  | No            |                  2 | On Loan: No      |
| CVS Health Corp                                | CVS Health Corp                                       | CUSIP: 126650100<br>LEI: 549300EJG376EN5NQE29 | Long             | EC               | CORP              | US        |    822169 | NS      | $76617929.11  | 1.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Illumina Inc                                   | Illumina Inc                                          | CUSIP: 452327109<br>LEI: SQ95QG8SR5Q56LSNF682 | Long             | EC               | CORP              | US        |     99018 | NS      | $20021439.60  | 0.45%             |  |  |  | No            |                  1 | On Loan: —       |
| Astellas Pharma Inc                            | Astellas Pharma Inc                                   | CUSIP: 000000000<br>LEI: 529900IB708DY2HBBB35 | Long             | EC               | CORP              | JP        |   1152375 | NS      | $17522585.81  | 0.39%             |  |  |  | No            |                  2 | On Loan: No      |
| Smith & Nephew PLC                             | Smith & Nephew PLC                                    | CUSIP: 000000000<br>LEI: 213800ZTMDN8S67S1H61 | Long             | EC               | CORP              | GB        |    554250 | NS      | $7401908.10   | 0.17%             |  |  |  | No            |                  2 | On Loan: No      |
| Eisai Co Ltd                                   | Eisai Co Ltd                                          | CUSIP: 000000000<br>LEI: 353800HDEE0ZYEX4QV91 | Long             | EC               | CORP              | JP        |    186500 | NS      | $12300054.18  | 0.28%             |  |  |  | No            |                  2 | On Loan: No      |
| Rede D'Or Sao Luiz SA                          | Rede D'Or Sao Luiz SA                                 | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | BR        |    470900 | NS      | $2630505.06   | 0.06%             |  |  |  | No            |                  2 | On Loan: No      |
| Incyte Corp                                    | Incyte Corp                                           | CUSIP: 45337C102<br>LEI: 549300Z4WN6JVZ3T4680 | Long             | EC               | CORP              | US        |    115161 | NS      | $9249731.52   | 0.21%             |  |  |  | No            |                  1 | On Loan: —       |
| Fresenius Medical Care AG & Co KGaA            | Fresenius Medical Care AG & Co KGaA                   | CUSIP: 000000000<br>LEI: 549300CP8NY40UP89Q40 | Long             | EC               | CORP              | DE        |    126844 | NS      | $4143043.79   | 0.09%             |  |  |  | No            |                  2 | On Loan: No      |
| AstraZeneca PLC                                | AstraZeneca PLC                                       | CUSIP: 000000000<br>LEI: PY6ZZQWO2IZFZC3IOL08 | Long             | EC               | CORP              | GB        |    975399 | NS      | $131990360.06 | 2.97%             |  |  |  | No            |                  2 | On Loan: No      |
| Intuitive Surgical Inc                         | Intuitive Surgical Inc                                | CUSIP: 46120E602<br>LEI: 54930052SRG011710797 | Long             | EC               | CORP              | US        |    223406 | NS      | $59280782.10  | 1.34%             |  |  |  | No            |                  1 | On Loan: No      |
| Fresenius SE & Co KGaA                         | Fresenius SE & Co KGaA                                | CUSIP: 000000000<br>LEI: XDFJ0CYCOO1FXRFTQS51 | Long             | EC               | CORP              | DE        |    257691 | NS      | $7197794.86   | 0.16%             |  |  |  | No            |                  2 | On Loan: No      |
| Amgen Inc                                      | Amgen Inc                                             | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |    335886 | NS      | $88217099.04  | 1.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Alcon Inc                                      | Alcon Inc                                             | CUSIP: 000000000<br>LEI: 549300LDT5AP8S0NBM78 | Long             | EC               | CORP              | CH        |    313425 | NS      | $21506895.38  | 0.48%             |  |  |  | No            |                  2 | On Loan: No      |
| Ono Pharmaceutical Co Ltd                      | Ono Pharmaceutical Co Ltd                             | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | JP        |    295900 | NS      | $6916240.89   | 0.16%             |  |  |  | No            |                  2 | On Loan: No      |
| Organon & Co                                   | Organon & Co                                          | CUSIP: 68622V106<br>LEI: 549300AMCKY57OK2CO56 | Long             | EC               | CORP              | US        |    160134 | NS      | $4472542.62   | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Abbott Laboratories                            | Abbott Laboratories                                   | CUSIP: 002824100<br>LEI: HQD377W2YR662HK5JX27 | Long             | EC               | CORP              | US        |   1096303 | NS      | $120363106.37 | 2.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Lonza Group AG                                 | Lonza Group AG                                        | CUSIP: 000000000<br>LEI: 549300EFW4H2TCZ71055 | Long             | EC               | CORP              | CH        |     46606 | NS      | $22877738.96  | 0.52%             |  |  |  | No            |                  2 | On Loan: No      |
| CSL Ltd                                        | CSL Ltd                                               | CUSIP: 000000000<br>LEI: 529900ECSECK5ZDQTE14 | Long             | EC               | CORP              | AU        |    303553 | NS      | $59191055.74  | 1.33%             |  |  |  | No            |                  2 | On Loan: No      |
| Dexcom Inc                                     | Dexcom Inc                                            | CUSIP: 252131107<br>LEI: 549300YSK3QDSFR5EU59 | Long             | EC               | CORP              | US        |    246180 | NS      | $27877423.20  | 0.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Roche Holding AG                               | Roche Holding AG                                      | CUSIP: 000000000<br>LEI: 549300U41AUUVOAAOB37 | Long             | EC               | CORP              | CH        |     16764 | NS      | $6495983.63   | 0.15%             |  |  |  | No            |                  2 | On Loan: No      |
| Pfizer Inc                                     | Pfizer Inc                                            | CUSIP: 717081103<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | EC               | CORP              | US        |   3533569 | NS      | $181060075.56 | 4.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Hoya Corp                                      | Hoya Corp                                             | CUSIP: 000000000<br>LEI: 353800X4VR3BHEUCJB42 | Long             | EC               | CORP              | JP        |    224800 | NS      | $21531008.38  | 0.48%             |  |  |  | No            |                  2 | On Loan: No      |
| Bio-Techne Corp                                | Bio-Techne Corp                                       | CUSIP: 09073M104<br>LEI: 54930073RLKQ51TILZ35 | Long             | EC               | CORP              | US        |     98062 | NS      | $8127378.56   | 0.18%             |  |  |  | No            |                  1 | On Loan: —       |
| Molina Healthcare Inc                          | Molina Healthcare Inc                                 | CUSIP: 60855R100<br>LEI: 549300NQQCEQ46YHZ591 | Long             | EC               | CORP              | US        |     36465 | NS      | $12041472.30  | 0.27%             |  |  |  | No            |                  1 | On Loan: No      |
| UCB SA                                         | UCB SA                                                | CUSIP: 000000000<br>LEI: 2138008J191VLSGY5A09 | Long             | EC               | CORP              | BE        |     79582 | NS      | $6270540.11   | 0.14%             |  |  |  | No            |                  2 | On Loan: No      |
| Edwards Lifesciences Corp                      | Edwards Lifesciences Corp                             | CUSIP: 28176E108<br>LEI: YA13X31F3V31L8TMPR58 | Long             | EC               | CORP              | US        |    388288 | NS      | $28970167.68  | 0.65%             |  |  |  | No            |                  1 | On Loan: —       |
| Chicago Mercantile Exchange                    | XAV HEALTH CARE MAR23                                 | CUSIP: 000000000<br>LEI: SNZ2OJLFK8MNNCLQOF39 | N/A              | DE               |  | US        |        70 | NC      | $-284626.18   | -0.01%            |  |  |  | No            |                  1 | On Loan: No      |
| Cardinal Health Inc                            | Cardinal Health Inc                                   | CUSIP: 14149Y108<br>LEI: CCU46N3GJMF4OK4N7U60 | Long             | EC               | CORP              | US        |    170013 | NS      | $13068899.31  | 0.29%             |  |  |  | No            |                  1 | On Loan: No      |
| AmerisourceBergen Corp                         | AmerisourceBergen Corp                                | CUSIP: 03073E105<br>LEI: AI8GXW8LG5WK7E9UD086 | Long             | EC               | CORP              | US        |    101293 | NS      | $16785263.03  | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Bayer AG                                       | Bayer AG                                              | CUSIP: 000000000<br>LEI: 549300J4U55H3WP1XT59 | Long             | EC               | CORP              | DE        |    618432 | NS      | $31830724.90  | 0.72%             |  |  |  | No            |                  2 | On Loan: No      |
| Sanofi                                         | Sanofi                                                | CUSIP: 000000000<br>LEI: 549300E9PC51EN656011 | Long             | EC               | CORP              | FR        |    726064 | NS      | $70011832.25  | 1.58%             |  |  |  | No            |                  2 | On Loan: No      |
| Laboratory Corp of America Holdings            | Laboratory Corp of America Holdings                   | CUSIP: 50540R409<br>LEI: OZ7UA8IXAIFILY2VZH07 | Long             | EC               | CORP              | US        |     56385 | NS      | $13277539.80  | 0.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Merck KGaA                                     | Merck KGaA                                            | CUSIP: 000000000<br>LEI: 529900OAREIS0MOPTW25 | Long             | EC               | CORP              | DE        |     80967 | NS      | $15621790.94  | 0.35%             |  |  |  | No            |                  2 | On Loan: No      |
| Sysmex Corp                                    | Sysmex Corp                                           | CUSIP: 000000000<br>LEI: 5299001ZO4CKWACMZI55 | Long             | EC               | CORP              | JP        |    106000 | NS      | $6399281.34   | 0.14%             |  |  |  | No            |                  2 | On Loan: No      |
| EssilorLuxottica SA                            | EssilorLuxottica SA                                   | CUSIP: 000000000<br>LEI: 549300M3VH1A3ER1TB49 | Long             | EC               | CORP              | FR        |    191519 | NS      | $34652098.93  | 0.78%             |  |  |  | No            |                  2 | On Loan: No      |
| HCA Healthcare Inc                             | HCA Healthcare Inc                                    | CUSIP: 40412C101<br>LEI: 529900PH4ZGUH2MNEU89 | Long             | EC               | CORP              | US        |    134891 | NS      | $32368444.36  | 0.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Bio-Rad Laboratories Inc                       | Bio-Rad Laboratories Inc                              | CUSIP: 090572207<br>LEI: 549300ZC1GPV35XYDK53 | Long             | EC               | CORP              | US        |     13481 | NS      | $5668625.69   | 0.13%             |  |  |  | No            |                  1 | On Loan: —       |
| Terumo Corp                                    | Terumo Corp                                           | CUSIP: 000000000<br>LEI: 353800JX1R4582QVK932 | Long             | EC               | CORP              | JP        |    477900 | NS      | $13548739.87  | 0.31%             |  |  |  | No            |                  2 | On Loan: No      |
| Takeda Pharmaceutical Co Ltd                   | Takeda Pharmaceutical Co Ltd                          | CUSIP: 000000000<br>LEI: 549300ZLMVP4X0OGR454 | Long             | EC               | CORP              | JP        |    995892 | NS      | $31118308.46  | 0.70%             |  |  |  | No            |                  2 | On Loan: No      |
| McKesson Corp                                  | McKesson Corp                                         | CUSIP: 58155Q103<br>LEI: 549300WZWOM80UCFSF54 | Long             | EC               | CORP              | US        |     90001 | NS      | $33761175.12  | 0.76%             |  |  |  | No            |                  1 | On Loan: No      |
| Humana Inc                                     | Humana Inc                                            | CUSIP: 444859102<br>LEI: 529900YLDW34GJAO4J06 | Long             | EC               | CORP              | US        |     79210 | NS      | $40570569.90  | 0.91%             |  |  |  | No            |                  1 | On Loan: No      |
| Eurofins Scientific SE                         | Eurofins Scientific SE                                | CUSIP: 000000000<br>LEI: 529900JEHFM47DYY3S57 | Long             | EC               | CORP              | LU        |     81127 | NS      | $5824766.49   | 0.13%             |  |  |  | No            |                  2 | On Loan: —       |
| Danaher Corp                                   | Danaher Corp                                          | CUSIP: 235851102<br>LEI: S4BKK9OTCEWQ3YHPFM11 | Long             | EC               | CORP              | US        |    412424 | NS      | $109465578.08 | 2.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Regeneron Pharmaceuticals Inc                  | Regeneron Pharmaceuticals Inc                         | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |     67408 | NS      | $48634197.92  | 1.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Shionogi & Co Ltd                              | Shionogi & Co Ltd                                     | CUSIP: 000000000<br>LEI: 35380049VXDTHZI3DY35 | Long             | EC               | CORP              | JP        |    178300 | NS      | $8895942.44   | 0.20%             |  |  |  | No            |                  2 | On Loan: No      |
| Teleflex Inc                                   | Teleflex Inc                                          | CUSIP: 879369106<br>LEI: UUL85LWXB4NGSWWXIQ25 | Long             | EC               | CORP              | US        |     29534 | NS      | $7372572.42   | 0.17%             |  |  |  | No            |                  1 | On Loan: No      |
| Grifols SA                                     | Grifols SA                                            | CUSIP: 000000000<br>LEI: 959800HSSNXWRKBK4N60 | Long             | EC               | CORP              | ES        |    192675 | NS      | $2225089.59   | 0.05%             |  |  |  | No            |                  2 | On Loan: —       |
| Sartorius Stedim Biotech                       | Sartorius Stedim Biotech                              | CUSIP: 000000000<br>LEI: 52990006IVXY7GCSSR39 | Long             | EC               | CORP              | FR        |     15062 | NS      | $4894667.22   | 0.11%             |  |  |  | No            |                  2 | On Loan: No      |
| Novartis AG                                    | Novartis AG                                           | CUSIP: 000000000<br>LEI: 5493007HIVTX6SY6XD66 | Long             | EC               | CORP              | CH        |   1513135 | NS      | $136934811.31 | 3.08%             |  |  |  | No            |                  2 | On Loan: No      |
| Mettler-Toledo International Inc               | Mettler-Toledo International Inc                      | CUSIP: 592688105<br>LEI: 5493000BD5GJNUDIUG10 | Long             | EC               | CORP              | US        |     14066 | NS      | $20331699.70  | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Sonic Healthcare Ltd                           | Sonic Healthcare Ltd                                  | CUSIP: 000000000<br>LEI: 549300NQQ5L2NONWR862 | Long             | EC               | CORP              | AU        |    300816 | NS      | $6121914.01   | 0.14%             |  |  |  | No            |                  2 | On Loan: No      |
| Merck & Co Inc                                 | Merck & Co Inc                                        | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |   1596026 | NS      | $177079084.70 | 3.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Cooper Cos Inc/The                             | Cooper Cos Inc/The                                    | CUSIP: 216648402<br>LEI: QJKMVPIGLH7530PCUE20 | Long             | EC               | CORP              | US        |     30967 | NS      | $10239857.89  | 0.23%             |  |  |  | No            |                  1 | On Loan: —       |
| Coloplast A/S                                  | Coloplast A/S                                         | CUSIP: 000000000<br>LEI: 529900NN7SOJ5QG82X67 | Long             | EC               | CORP              | DK        |     74584 | NS      | $8737712.21   | 0.20%             |  |  |  | No            |                  2 | On Loan: No      |
| Quest Diagnostics Inc                          | Quest Diagnostics Inc                                 | CUSIP: 74834L100<br>LEI: 8MCWUBXQ0WE04KMXBX50 | Long             | EC               | CORP              | US        |     73374 | NS      | $11478628.56  | 0.26%             |  |  |  | No            |                  1 | On Loan: No      |
| STERIS PLC                                     | STERIS PLC                                            | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | IE        |     62842 | NS      | $11606288.98  | 0.26%             |  |  |  | No            |                  1 | On Loan: No      |
| West Pharmaceutical Services Inc               | West Pharmaceutical Services Inc                      | CUSIP: 955306105<br>LEI: 5493007NKRGM1RJQ1P16 | Long             | EC               | CORP              | US        |     46171 | NS      | $10866344.85  | 0.24%             |  |  |  | No            |                  1 | On Loan: No      |
| Waters Corp                                    | Waters Corp                                           | CUSIP: 941848103<br>LEI: 5T547R1474YC9HOD8Q74 | Long             | EC               | CORP              | US        |     37557 | NS      | $12866277.06  | 0.29%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co                                 | Eli Lilly & Co                                        | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |    496452 | NS      | $181621999.68 | 4.09%             |  |  |  | No            |                  1 | On Loan: No      |
| QIAGEN NV                                      | QIAGEN NV                                             | CUSIP: 000000000<br>LEI: 54930036WK3GMCN17Z57 | Long             | EC               | CORP              | NL        |    145767 | NS      | $7327780.20   | 0.17%             |  |  |  | No            |                  2 | On Loan: No      |
| Henry Schein Inc                               | Henry Schein Inc                                      | CUSIP: 806407102<br>LEI: VGO3WGL8H45T73F4RR92 | Long             | EC               | CORP              | US        |     84890 | NS      | $6780164.30   | 0.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Catalent Inc                                   | Catalent Inc                                          | CUSIP: 148806102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    112744 | NS      | $5074607.44   | 0.11%             |  |  |  | No            |                  1 | On Loan: No      |
| IDEXX Laboratories Inc                         | IDEXX Laboratories Inc                                | CUSIP: 45168D104<br>LEI: OGMTXK0LUU1HKV2P0J84 | Long             | EC               | CORP              | US        |     52100 | NS      | $21254716.00  | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Hologic Inc                                    | Hologic Inc                                           | CUSIP: 436440101<br>LEI: 549300DYP6F5ZJL0LB74 | Long             | EC               | CORP              | US        |    155993 | NS      | $11669836.33  | 0.26%             |  |  |  | No            |                  1 | On Loan: —       |
| Baxter International Inc                       | Baxter International Inc                              | CUSIP: 071813109<br>LEI: J5OIVXX3P24RJRW5CK77 | Long             | EC               | CORP              | US        |    314385 | NS      | $16024203.45  | 0.36%             |  |  |  | No            |                  1 | On Loan: No      |
| Bristol-Myers Squibb Co                        | Bristol-Myers Squibb Co                               | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |   1338411 | NS      | $96298671.45  | 2.17%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences Inc                            | Gilead Sciences Inc                                   | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |    789542 | NS      | $67782180.70  | 1.53%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2023-01-31

**Name of Applicant:** iShares Trust

**Signature:** Ann Frechette

**Name of Signer:** Ann Frechette

**Title:** Assistant Treasurer